Emergent BioSolutions to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025

Core Points - Emergent BioSolutions Inc. will host a conference call on March 3, 2025, to discuss the financial results for Q4 and full year 2024 [1] - The company will also present at J.P. Morgan's 2025 Leveraged Finance Conference on February 24, 2025 [4] Company Overview - Emergent BioSolutions has been operational for over 25 years, focusing on public health threats through vaccines and therapeutics [5] - The company aims to protect or enhance 1 billion lives by 2030 [5] Investor Engagement - Participants can access the conference call via webcast or telephone, with pre-registration required for telephone participation [2] - A replay of the conference call will be available on the Investors page of Emergent's website [3]